Frontage Laboratories Revenue and Competitors

Lionville, PA USA

Location

$32.4M

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Frontage Laboratories's estimated annual revenue is currently $174.7M per year.(i)
  • Frontage Laboratories's estimated revenue per employee is $281,400
  • Frontage Laboratories's total funding is $32.4M.

Employee Data

  • Frontage Laboratories has 621 Employees.(i)
  • Frontage Laboratories grew their employee count by 2% last year.

Frontage Laboratories's People

NameTitleEmail/Phone
1
Executive Director, Marketing and Sales OperationsReveal Email/Phone
2
CEOReveal Email/Phone
3
Chief Scientific OfficerReveal Email/Phone
4
Sr. VP Global Safety & ToxicologyReveal Email/Phone
5
Executive Director Business DevelopmentReveal Email/Phone
6
VP Genomic ServicesReveal Email/Phone
7
VP, Global Project Management & Scientific AffairsReveal Email/Phone
8
VP, Scientific OperationsReveal Email/Phone
9
VP and General CounselReveal Email/Phone
10
EVP, CMC ServicesReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$43.2M2156%N/AN/A
#2
$81.8M40710%N/AN/A
#3
$11.7M580%N/AN/A
#4
$1011.8M5034-9%N/AN/A
#5
$44.8M2231%N/AN/A
#6
$13.1M655%N/AN/A
#7
$16.5M8241%N/AN/A
#8
$17.3M86-5%N/AN/A
#9
$67.9M33823%N/AN/A
#10
$14.9M747%N/AN/A
Add Company

What Is Frontage Laboratories?

About Frontage Laboratories, Inc. Frontage Laboratories, Inc. is a rapidly expanding pharmaceutical R&D services company located in the greater Philadelphia, PA area and Shanghai, P.R. China. Recognizing the importance of developing cost-effective and efficacious pharmaceutical treatments, Frontage collaborates with clients to discover and develop new cures and healthcare advances. In addition, leading pharmaceutical companies call on Frontage to solve complex development issues and advance their pharmaceutical products through FDA approval. Frontage provides support in the following areas: GMP synthesis of investigational chemical entities (including route selection and scale-up), Preclinical studies and bioanalysis, Phase I - IV clinical trial services and bioanalytical support, Biomarker research and clinical testing, GMP/GLP pharmaceutical analysis (including raw material and finished product release, stability studies and regulatory support), formulation development in preclinical, clinical and commercial stages, clinical materials manufacture and packaging, as well as GMP consulting and regulatory filing.

keywords:N/A

$32.4M

Total Funding

621

Number of Employees

$174.7M

Revenue (est)

2%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Frontage Laboratories News

2022-03-30 - Silo Pharma contracts Frontage Labs for pharmacokinetic ...

Silo Pharma (OTCQB:SILO) signed an agreement with contract research organization Frontage Laboratories for a pharmacokinetic study in...

2022-03-22 - Oragenics Initiates a Pivotal IND-Enabling Toxicology Study ...

Oragenics has contracted with Frontage Laboratories (through its wholly owned subsidiary Experimur) to conduct the study, with top-line...

2021-09-08 - Frontage Expands Early Drug Discovery Services through the Acquisition of Heyan Biotech

SHANGHAI, Sept. 8, 2021 /PRNewswire/ -- Frontage Shanghai announced the acquisition of 70% equity interest in Wuhan Heyan Biomedical Technology Co., Ltd. ("Heyan Biotech") Heyan Biotech, located in Wuhan Optics Valley, national biotech industry base, provides for target based in vitro pharmac ...

2008-12-02 - PRA International Announces Collaboration With Frontage Laboratories Inc.

Partnership extends PRA bioanalytical services in North America 2 December 2008, Raleigh, N.C. — PRA International, a leading Clinical Research Organization (CRO), announced today a collaborative agreement with Frontage Laboratories Inc. This partnership enables PRA Early Development Services’ ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$241.5M704-1%N/A
#2
$192.8M9304%$104.4M
#3
$435.3M12694%N/A
#4
$759.4M2009-9%N/A
#5
$426.7M21779%N/A